Skip to content
Tirzepatide Report
Provider review

MedLeanRx Tirzepatide Review: Texas Plans and Refund Terms

Researched & written by Alan PierceClinical Pharmacology WriterUpdated

On this page

MedLeanRx describes Texas-based weight care with separate compounded, limited-dose bundle and brand-care offers.

Standout details

  • Publishes qualified $269 monthly tirzepatide injection pricing
  • Separate Texas-only $325 total eight-week 2 mg weekly promotion while supplies last

Things to consider

  • Texas access must be confirmed for the selected service
  • Eight-week promotion is not a standard monthly renewal or dose recommendation

MedLeanRx's current product page lists tirzepatide injections at $269 per month, subject to dose and treatment needs. A separate promotion offers eight weeks at 2 mg weekly for $325. That limited-dose bundle is not a standard monthly renewal rate or a suitable dose recommendation for everyone. A clinician must determine the actual treatment.3,4

Keep three offers separate

The $325 promotion is described as two months or eight weeks, a total rather than a $325 monthly payment. Dividing by the advertised two months gives $162.50 per month equivalent; it does not turn eight weeks into two calendar months or establish a recurring charge. The offer is Texas-only and while supplies last, with approval required. Confirm medication quantity, concentration, usable period and what happens after week eight.4

For a brand-name Zepbound pathway, the product page lists a $99 monthly fee plus medication cost. That is not a $99 medication-inclusive tirzepatide plan. The general $149 starting headline is associated with other GLP-1 products and starting-dose conditions; it should not replace the tirzepatide-specific price.3

TopicWhat to know
Compounded injection$269/month listed; dose and needs may change price
Limited promotion$325 for eight weeks at 2 mg weekly
Promotion equivalent$162.50 per advertised month; not installments
Brand-care pathway$99/month fee plus medication cost
The eight-week promotion is limited-dose and Texas-only; clinician approval required.3,4

Payment is required before review

The terms require payment before services and state that payment does not guarantee treatment approval, medication or a prescription. Fees cover provider review, administration, coordination and related services. The terms declare sales final and list consultations, reviews, subscription, administrative, membership and rendered-service fees as nonrefundable. They do not promise a full refund when a clinician declines prescribing.5

Ask for the amount retained if not approved, whether medication charges are collected separately, and any exception before paying. The retrieved terms do not provide a complete subscription cancellation method, notice period or unused-prepaid allocation. Do not infer those details from a general FAQ question or a cancel-anytime expectation. Obtain the next charge, renewal consent and cancellation deadline in the accepted agreement.5

Delivery is not guaranteed for every medication: the terms make home fulfillment dependent on the prescribed product, payment or insurance situation and state rules. Confirm any supplies, shipping, labs and follow-up charges in the quote rather than treating a generic headline as universally all-inclusive.5

TopicWhat to know
Payment timingBefore services; prescription not guaranteed
Refund termsListed care/platform fees nonrefundable
Renewal questionsGet method, deadline and next charge in writing
Care and pharmacyTexas program; named supervisor, assigned dispenser unverified
Confirm the governing selected agreement before authorizing payment.5,6

Texas access and accountable care

The current website describes care for patients in Texas, including Houston, Dallas, Austin and San Antonio. It names Johnson Uzor, MD, as supervising physician. This is an attributed disclosure, not independent current-license verification or proof that he personally evaluates every patient. Ask for the actual treating clinician and practice and confirm where you must be physically located during the consultation.3,6

The retrieved product and terms pages do not establish the preparing and dispensing pharmacy assigned to the selected prescription. Obtain the exact legal name, address, formulation and storage instructions before treatment. A displayed certification seal is not sufficient to verify current credentials or a specific facility's role.

Decide using the selected plan

MedLeanRx offers both a compounded injection pathway and a separately priced brand-care service. Compounded products are not FDA-approved, as its terms acknowledge; the original brand-drug trial references do not establish results for the specific compounded preparation or a nonstandard starting dose.1,2,5 The useful comparison is the complete post-promotion cost and payment risk, together with the clinician and pharmacy responsible for your care.

Further reading

Compounded Tirzepatide Legal Status, Zepbound Side Effects, Tirzepatide Gallbladder, Tirzepatide Thyroid Cancer Warning, Tirzepatide Evidence Guide, Coreage Rx Review, Best/Tirzepatide.

Frequently asked questions

How much is MedLeanRx tirzepatide?

The product page lists $269 monthly, with dose and treatment qualifications. A separate $325 offer supplies eight weeks at 2 mg weekly; it is not the standard monthly renewal price.

Is Zepbound included for $99?

No. The brand-care pathway is listed at $99 per month plus medication cost. Obtain the total for the prescribed product and confirm insurance or cash-payment conditions.

Will I get a refund if not approved?

The terms require payment first and do not promise approval or a full nonapproval refund. They make listed care and platform fees nonrefundable; ask for the retained amount and cancellation terms before paying.

References(6)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. MedLeanRx (2026). Current products and price qualifications. MedLeanRx.
  4. MedLeanRx (2026). Eight-week tirzepatide promotion. MedLeanRx.
  5. MedLeanRx (2026). Terms and payment/no-refund policy. MedLeanRx.
  6. MedLeanRx (2026). Supervising physician disclosure. MedLeanRx.

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.